Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial

No Thumbnail Available

Authors

Casale, Thomas
Maurer, Marcus
Hsieh, Hsin-Ju
Canvin, Janice
Saini, Sarbjit S.
Grattan, Clive
Gimenez-Arnau, Ana
Kaplan, Allen P.
Rosen, Karin

Issue Date

2013

Volume

131

Issue

2, Supplement

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Casale, Thomas; Maurer, Marcus; Hsieh, Hsin-Ju; Canvin, Janice; Saini, Sarbjit S.; Grattan, Clive; Gimenez-Arnau, Ana; Kaplan, Allen P.; Rosen, Karin. Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Allergy and Clinical Immunology. 2013, 131(2, Supplement):AB327.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/60786

PubMed ID

DOI

Identifier

Additional link

http://cuhsl.creighton.edu/login?url=http://kc7za5wx4c.search.serialssolutions.com/?sid=Refworks%3A&charset=utf-8&__char_set=utf8&genre=article&aulast=Casale&auinit=T.&title=Journal%20of%20Allergy%20and%20Clinical%20Immunology&date=2013&volume=131&pages=AB327&issue=2%2C%20Supplement&issn=0091-6749&atitle=Efficacy%20and%20Safety%20of%20Omalizumab%20in%20Chronic%20Idiopathic%2FSpontaneous%20Urticaria%20(CIU%2FCSU)%3A%20Results%20From%20a%20Phase%20III%2C%20Randomized%2C%20Double-Blind%2C%20Placebo-Controlled%20Trial&spage=AB327&au=Casale%2CThomas&au=Maurer%2CMarcus&au=Hsieh%2CHsin-Ju&au=Canvin%2CJanice&au=Saini%2CSarbjit%20S.&au=Grattan%2CClive&au=Gimenez-Arnau%2CAna&au=Kaplan%2CAllen%20P.&au=Rosen%2CKarin&

ISSN

0091-6749
1097-6825

EISSN

Collections